Τόμος 14 (1996) – Τεύχος 2 – Άρθρο 1 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 14 (1996) – Issue 2 – Article 1 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Βασίλειος Κόκκας

Ερ­γα­στή­ριο Φαρ­μα­κο­λο­γί­ας, Ια­τρι­κή Σχο­λή Α­ρι­στο­τε­λεί­ου Πα­νε­πι­στη­μί­ου Θεσ­σα­λο­νί­κης

Basilis Kokkas

Laboratory of Pharmacology, Faculty of Medi­cine, Aristotle University of Thessaloniki, Greece

1. Dzau D.V., Creager M.: Vascular diseases of the ex­tremities. In: Harisson’s Principles of Internal Medi­cine (J. Wilson, E. Braunwald, K. Isselbacher, R. Peterdorf, J. Mar­tin, H. Fauci, R. Root, eds). p.1018, McGraw-Hill, Íew York, 1991.
2. Tunstall Pedoe D. and Walkery: Cardiovascular disease In.: Textbook of Medicine (Souhami R. and Moxham J, eds) p. 329, Churchill Livingstone New York 1990
3. Kiesewetter H., Jung F., Junger M, Marx U., Koscielny J.: Chronic venous insufficiency: only a macro of also a microangiopathy? Clin. Hemorheol­. 14 (Suppl. I): 65-78 (1994)
4. Reynolds J. (ed): Martindale. The Extra Pharmaco­poeia. The Pharmaceutical Press, London, 1989
5. Nieberle F., Schmidt G.: Protective action of hes­peridin trimethylchalcone and Ruscus aculeatus against ethacrynic acid oedema in the hind leg of the anaes­thetical cat. Phle­bol. V. Proktol. 12: 209-218 (1983)
6. Σου­λε­λές, Χρ.: Μα­θή­μα­τα Φαρ­μα­κο­γνω­σί­ας, Θεσ­σα­λο­νί­κη 1995
7. Σου­λε­λές, Χρ.: Γε­νι­κή Φαρ­μα­κο­γνω­σί­α Θεσ­σα­λο­νί­κη, 1995
8. Potier P.: Relationship between chemical structure and pharmacological properties of the constituents of Ruscus Aculeatus. Intern. Angiol. 3: 68-69 (1984)
9. Marcelon G., Vanhoute P.: Mechanism of action of Ru­scus extract. Intern. Angiol. 1: 74-76 (1984)
10. Domange J., Bougaret S., Yubero L.: Pharmacologi­cal studies of Cyclo 3 fort and its constituents (Ruscus extract, hesperidin methyl chalcone, ascorbic acid) an up to date review. Clin. Hemorheol. 14 (Suppl. I): 7-13 (1994)
11. Lauressergues H., Vilain P.: Pharmacological activities of Ruscus extract on venous smooth muscle. Intern. Angiol. 1: 70-73 (1984)
12. Pouget G, Ducros L., Marcelon G.: Effect of Ruscus ex­tract on peripheral lymphatic vessel pressure and flow. In: Return circulation and norepinephrine (P. Vanhoute, J. Lib­bey, eds.) p. 89, Eurotext, Paris, 1991
13. Miller B., Marcelon G., Vanhoute P.: Ruscus extract releases endothelium derived relaxing factor in arteries and veins. In: Return circulation and norepi­nephrine (P. Van­houte, J. Libbey, eds p. 31, Eurotext, Paris, 1991
14. Schulz R., Trifle Ch.: Role of NO in vascular smooth muscle and cardiac muscle function. Trends Pharmacol. Sci 15: 255-259 (1994)
15. MacGalland T., Vallance P.: Nitric oxide takes centre-stage with newly defined roles. Trends Pharma­col Sci 13: 1-5 (1992)
16. Vanhoute P.: Alpha-adrenergic effects of Ruscus acu­leatus on cutaneous veins. Modulation by local temperature. In: Advances in medicinal phytochemistry (D. Barton, W. Ollis, eds). p. 187, John Libbey, London, 1986
17. Felix W., Nieberle J., Schmidt G.: Protective action of Hesperidin trimethyl chalcone and Ruscus aculeatus against ethacrynic acid oedema in the hind leg of the anaesthe­tised cat. Phlebol. V. Proctol. 12: 209-218 (1983)
18. Bouskela E., Cyrino A.: Possible mechanisms for the effort of Ruscus extract on microvascular perme­ability and diameter. Clin. Hemorheol. 14 (Suppl. I): 23-36 (1994)
19. Baurain R., Dom G., Tronet A.: Protective effect of cyclo 3 fort and its constituents for human endothelial cells under hypoxia. Clin Hemorheol. 14 (Suppl. I):  15-21 (1994).
20. 20. Barbe R., Amiel M.: Pharmacodynamic proper­ties and therapeutic efficacy of Daflon 500mg. Phlebol­ogy Suppl. 2: 41-44 (1992)
21. Friesennecker B., Tsai A., Intaglietta M..: Cellular basis of inflammation, oedema and the activity of Daflon 500 mg. Int. J. Microcirc. 15 (Suppl I): 17-21 (1995)
22. Bouskela E., Cyrino F., Marcelon G.: Inhibitory effect of Ruscus extract and of the flavonoid Hesperidin methylchal­cone on increased microvascular perme­ability induced by venous agents in the hamster cheek pouch. J. Cardiovasc. Pharmacol. 22: 225-230 (1993)
23. Rodwell V.: Biosynthesis of the nutritionally nones­sen­tial aminoacids. In: Harper’s Biochemistry (Murray R., Granner D., Mayers P., Rodwell V., eds) p. 267, Appleton and Lange, Connect. USA, 1990
24. Rodwell B., Murray R., Keeley F.: Contractile and structural proteins. In: Harper’s Biochemistry (Murran R., Granner D., Meyers P., Rodwell V., eds) p. 627, Appleton and Lange, Connect. USA, 1990
25. Faden A., Salzman St.: Pharmacological strate­gies in CNS Trauma. Trends Pharmacol. Sci 13: 29-35 (1992)
26. Johnston A., Paul Hl, Young C.: Effects of microni­za­tion on digestive absorption of diosmin. Phlebology Suppl. 1: 4-6 (1994)
27. Le Devehat C., Khodabandehlon T., Vimeux M., Dougny M.: The effects of Cyclo 3-Fost treatment on hemorheological disturbances during a provoked venous stasis in patients with chronic venous insufficiency. Clin. Hemorheol. 14 (Suppl 1): 53-63 (1994)